Publicacións nas que colabora con María Carmen Martínez Oliva (21)

2013

  1. Influence of Vitamin D-Related Gene Polymorphisms (CYP27B and VDR) on the Response to Interferon/Ribavirin Therapy in Chronic Hepatitis C

    PLoS ONE, Vol. 8, Núm. 9

2012

  1. Analysis of the functional polymorphism in the cytochrome P450 CYP2C8 gene rs11572080 with regard to colorectal cancer risk

    Frontiers in Genetics, Vol. 3, Núm. DEC

  2. Polymorphism of the TLR4 gene reduces the risk of hepatitis C virus-induced hepatocellular carcinoma

    Oncology, Vol. 82, Núm. 1, pp. 35-40

  3. Predicting response to therapy in chronic hepatitis C: An approach combining interleukin-28B gene polymorphisms and clinical data

    Journal of Gastroenterology and Hepatology (Australia), Vol. 27, Núm. 2, pp. 279-285

  4. Relation of IL28b gene polymorphism with biochemical and histological features in hepatitis C virus-induced liver disease

    PLoS ONE, Vol. 7, Núm. 5

2008

  1. Interaction of CYP2C8 and CYP2C9 genotypes modifies the risk for nonsteroidal anti-inflammatory drugs-related acute gastrointestinal bleeding

    Pharmacogenetics and Genomics, Vol. 18, Núm. 1, pp. 37-43

2007

  1. Cytochrome P450 CYP2C9 Polymorphism and NSAID-Related Acute Gastrointestinal Bleeding

    Gastroenterology

  2. GSTT1 and GSTM1 null genotypes may facilitate hepatitis C virus infection becoming chronic

    Journal of Infectious Diseases, Vol. 195, Núm. 9, pp. 1320-1323

  3. Glutathione S-transferases π1, α1 and μ3 genetic polymorphisms and the risk of hepatocellular carcinoma in humans

    Pharmacogenomics, Vol. 8, Núm. 8, pp. 895-899

2006

  1. Glutathione S-transferase M1 and T1 genetic polymorphisms are not related to the risk of hepatocellular carcinoma: A study in the Spanish population

    European Journal of Cancer, Vol. 42, Núm. 1, pp. 73-77

  2. Glutathione S-transferases μ1, θ1, π1 α1 and μ3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans

    Pharmacogenomics, Vol. 7, Núm. 5, pp. 711-718

  3. Interethnic and intraethnic variability of CYP2C8 and CYP2C9 polymorphisms in healthy individuals

    Molecular Diagnosis and Therapy, Vol. 10, Núm. 1, pp. 29-40

  4. Severity of ulcerative colitis is associated with a polymorphism at diamine oxidase gene but not at histamine N-methyltransferase gene

    World Journal of Gastroenterology, Vol. 12, Núm. 4, pp. 615-620

2005

  1. Polymorphisms of the glutathione S-transferases mu-1 (GSTM1) and theta-1 (GSTT1) and the risk of advanced alcoholic liver disease

    Scandinavian Journal of Gastroenterology, Vol. 40, Núm. 3, pp. 348-353

  2. The effect of the cytochrome P450 CYP2C8 polymorphism on the disposition of (R)-ibuprofen enantiomer in healthy subjects

    British Journal of Clinical Pharmacology, Vol. 59, Núm. 1, pp. 62-68

2004

  1. Genetic predisposition to acute gastrointestinal bleeding after NSAIDs use

    British Journal of Pharmacology, Vol. 141, Núm. 2, pp. 205-208

2001

  1. Association of CYP2C9 genotypes leading to high enzyme activity and colorectal cancer risk

    Carcinogenesis, Vol. 22, Núm. 8, pp. 1323-1326

1998

  1. Expression in human prostate of drug- and carcinogen-metabolizing enzymes: Association with prostate cancer risk

    British Journal of Cancer, Vol. 78, Núm. 10, pp. 1361-1367

1996

  1. Identification and prevalence study of 17 allelic variants of the human NAT2 gene in a white population

    Pharmacogenetics, Vol. 6, Núm. 5, pp. 423-428

1990

  1. Oxidative polymorphism of debrisoquine in Parkinson's disease

    Journal of Neurology Neurosurgery and Psychiatry, Vol. 53, Núm. 4, pp. 289-292